Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesReceivables - OtherShares OutstandingShares Outstanding
Ratios

Odyssey Health (ODYY) Long-Term Debt Issuances (2016 - 2026)

Odyssey Health has reported Long-Term Debt Issuances over the past 7 years, most recently at -$1.2 million for Q3 2021.

  • For Q3 2021, Long-Term Debt Issuances fell 693.33% year-over-year to -$1.2 million; the TTM value through Jul 2021 reached $375000.0, up 650.0%, while the annual FY2025 figure was $300000.0, 25.0% down from the prior year.
  • Long-Term Debt Issuances for Q3 2021 was -$1.2 million at Odyssey Health, down from $1.1 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $1.1 million in Q2 2021 and troughed at -$1.2 million in Q3 2021.
  • A 5-year average of $46648.6 and a median of $50000.0 in 2020 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: surged 11200000.0% in 2017 and later plummeted 693.33% in 2021.
  • Year by year, Long-Term Debt Issuances stood at $53000.0 in 2017, then crashed by 64.15% to $19000.0 in 2018, then skyrocketed by 689.47% to $150000.0 in 2019, then soared by 110.0% to $315000.0 in 2020, then tumbled by 477.78% to -$1.2 million in 2021.
  • Business Quant data shows Long-Term Debt Issuances for ODYY at -$1.2 million in Q3 2021, $1.1 million in Q2 2021, and $150000.0 in Q1 2021.